The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses

Retrovirology

Volumn 9, Issue , 2012, Pages

  Lim, Efrem S ^a,b,d   Wu, Lily I ^b   Malik, Harmit S ^b,c   Emerman, Michael ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON INDUCING AGENT; UNCLASSIFIED DRUG; VIPERIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EVOLUTION; GENE SILENCING; GENETIC SELECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LYMPHOID CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RETROVIRUS; TARGET CELL; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS RELEASE; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; EVOLUTION, MOLECULAR; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; PHYLOGENY; PRIMATES; PROTEINS; SELECTION, GENETIC; TRANSFECTION; U937 CELLS; VIRUS INTERNALIZATION; VIRUS RELEASE;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; WEST NILE VIRUS;

EID: 84862689295     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-55     Document Type: Article

References (50)

1. Emerman M, Malik H. Paleovirology-modern consequences of ancient viruses. PLoS Biol 2010, 8:e1000301. 10.1371/journal.pbio.1000301, 2817711, 20161719.
2. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. The Ability of Primate Lentiviruses to Degrade the Monocyte Restriction Factor SAMHD1 Preceded the Birth of the Viral Accessory Protein Vpx. Cell Host Microbe 2012, 11:194-204. 10.1016/j.chom.2012.01.004, 22284954.
3. Lim ES, Malik HS, Emerman M. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J Virol 2010, 84:7124-7134. 10.1128/JVI.00468-10, 2898239, 20444900.
4. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 2005, 102:2832-2837. 10.1073/pnas.0409853102, 549489, 15689398.
5. Mattijssen S, Pruijn GJ. Viperin, a key player in the antiviral response. Microbes Infect 2012, 14(5):419-426. 10.1016/j.micinf.2011.11.015, 22182524.
6. Seo JY, Yaneva R, Cresswell P. Viperin: A Multifunctional, Interferon-Inducible Protein that Regulates Virus Replication. Cell Host Microbe 2011, 10:534-539. 10.1016/j.chom.2011.11.004, 3246677, 22177558.
7. Fitzgerald KA. The interferon inducible gene: Viperin. J Interferon Cytokine Res 2011, 31:131-135. 10.1089/jir.2010.0127, 3021329, 21142818.
8. Wang S, Wu X, Pan T, Song W, Wang Y, Zhang F, Yuan Z. Viperin inhibits Hepatitis C Virus replication by interfering with the binding of NS5A to host protein hVAP-33. J Gen Virol 2012, 93:83-92. 10.1099/vir.0.033860-0, 21957124.
9. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, McCartney EM, Jangra RK, Lemon SM, Beard MR. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 2011, 54:1506-1517. 10.1002/hep.24542, 22045669.
10. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005, 42:702-710. 10.1002/hep.20844, 16108059.
11. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 2008, 82:1665-1678. 10.1128/JVI.02113-07, 2258705, 18077728.
12. Chan YL, Chang TH, Liao CL, Lin YL. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J Virol 2008, 82:10455-10464. 10.1128/JVI.00438-08, 2573197, 18768981.
13. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 2011, 85(22):11557-11566. 10.1128/JVI.05519-11, 3209274, 21880757.
14. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 2001, 98:15125-15130. 10.1073/pnas.011593298, 64994, 11752458.
15. Seo JY, Yaneva R, Hinson ER, Cresswell P. Human Cytomegalovirus Directly Induces the Antiviral Protein Viperin to Enhance Infectivity. Science 2011, 32:1093-1097.
16. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2:96-105. 10.1016/j.chom.2007.06.009, 18005724.
17. Ono A, Freed EO. Role of lipid rafts in virus replication. Adv Virus Res 2005, 64:311-358.
18. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010, 11:688-699. 10.1038/nrm2977, 20861879.
19. Mañes S, del Real G, Martínez-A C. Pathogens: raft hijackers. Nat Rev Immunol 2003, 3:557-568. 10.1038/nri1129, 12876558.
20. Blanc M, Hsieh WY, Robertson KA, Watterson S, Shui G, Lacaze P, Khondoker M, Dickinson P, Sing G, Rodriguez-Martin S, et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 2011, 9:e1000598. 10.1371/journal.pbio.1000598, 3050939, 21408089.
21. Nitta T, Kuznetsov Y, McPherson A, Fan H. Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts. Proc Natl Acad Sci U S A 2010, 107:1190-1195. 10.1073/pnas.0908660107, 2824291, 20080538.
22. Pickl WF, Pimentel-Muiños FX, Seed B. Lipid rafts and pseudotyping. J Virol 2001, 75:7175-7183. 10.1128/JVI.75.15.7175-7183.2001, 114446, 11435598.
23. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 2001, 98:13925-13930. 10.1073/pnas.241320298, 61143, 11717449.
24. Meyerson NR, Sawyer SL. Two-stepping through time: mammals and viruses. Trends Microbiol 2011, 19:286-294. 10.1016/j.tim.2011.03.006, 21531564.
25. Perelman P, Johnson WE, Roos C, Seuanez HN, Horvath JE, Moreira MA, Kessing B, Pontius J, Roelke M, Rumpler Y, et al. A molecular phylogeny of living primates. PLoS Genet 2011, 7:e1001342. 10.1371/journal.pgen.1001342, 3060065, 21436896.
26. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD. GARD: a genetic algorithm for recombination detection. Bioinformatics 2006, 22:3096-3098. 10.1093/bioinformatics/btl474, 17110367.
27. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 1997, 13:555-556.
28. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 2005, 22:1208-1222. 10.1093/molbev/msi105, 15703242.
29. Elde NC, Child SJ, Geballe AP, Malik HS. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 2009, 457:485-489. 10.1038/nature07529, 2629804, 19043403.
30. Wout AB VT, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol 2005, 79:10053-10058. 10.1128/JVI.79.15.10053-10058.2005, 1181597, 16014965.
31. Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci U S A 2003, 100:8460-8465. 10.1073/pnas.1437453100, 166251, 12824470.
32. Arhel NJ, Kirchhoff F. Implications of Nef: host cell interactions in viral persistence and progression to AIDS. Curr Top Microbiol Immunol 2009, 339:147-175. 10.1007/978-3-642-02175-6_8, 20012528.
33. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
34. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252. 10.1016/j.chom.2008.03.001, 2474773, 18342597.
35. Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M. Continuous high-titer HIV-1 vector production. Nat Biotechnol 2003, 21:569-572. 10.1038/nbt815, 12679787.
36. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291. 253077, 3016298.
37. Evans DT, Serra-Moreno R, Singh RK, Guatelli JC. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 2010, 18:388-396. 10.1016/j.tim.2010.06.010, 2956607, 20688520.
38. Martin-Serrano J, Neil SJ. Host factors involved in retroviral budding and release. Nat Rev Microbiol 2011, 9:519-531. 10.1038/nrmicro2596, 21677686.
39. Rossman JS, Jing X, Leser GP, Lamb RA. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010, 142:902-913. 10.1016/j.cell.2010.08.029, 3059587, 20850012.
40. Rivieccio MA, Suh HS, Zhao Y, Zhao ML, Chin KC, Lee SC, Brosnan CF. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol 2006, 177:4735-4741.
41. Patel MR, Loo YM, Horner SM, Gale M, Malik HS. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol 2012, 10:e1001282. 10.1371/journal.pbio.1001282, 3302847, 22427742.
42. Lim ES, Emerman M. Simian immunodeficiency virus SIVagm from African green monkeys does not antagonize endogenous levels of African green monkey tetherin/BST-2. J Virol 2009, 83:11673-11681. 10.1128/JVI.00569-09, 2772663, 19726508.
43. Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann Neurol 1988, 23(Suppl):S58-61.
44. Poss M, Overbaugh J. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties. J Virol 1999, 73:5255-5264. 112580, 10364271.
45. Takehisa J, Kraus MH, Decker JM, Li Y, Keele BF, Bibollet-Ruche F, Zammit KP, Weng Z, Santiago ML, Kamenya S, et al. Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. J Virol 2007, 81:7463-7475. 10.1128/JVI.00551-07, 1933379, 17494082.
46. Regier DA, Desrosiers RC. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990, 6:1221-1231.
47. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992, 66:6547-6554. 240149, 1404602.
48. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25:4876-4882. 10.1093/nar/25.24.4876, 147148, 9396791.
49. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52:696-704. 10.1080/10635150390235520, 14530136.
50. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676-679. 10.1093/bioinformatics/bti079, 15509596.